Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Healthcare professionals should discuss these potential benefits when considering treatment options for appropriate patients
Diabetes Obes Metab (2018) 20:88997
If youre taking a weight loss medication and constantly wondering what to eat on Ozempic, or another GLP-1 receptor agonist, youve come to the right place
The observed reduction in AUD risk is particularly noteworthy given the global burden of AUD, which affects an estimated 280 million people and is associated with high morbidity and mortality [34]
GLP-1 medications may help reduce use of other addicting substances
For patients taking Rybelsus, realistic expectations include: Modest weight loss : Typically 35% of baseline body weight over 612 months Gradual progression : Weight loss occurs slowly, not rapidly Individual variation : Some patients may lose more or less than average Plateau effect : Weight loss often slows or stabilises after several months Patient safety considerations are paramount: Common side effects include nausea, vomiting, diarrhoea, and abdominal discomfort, particularly during dose escalation Rare but serious risks include pancreatitis and gallbladder disease [1] [4] If you experience severe, persistent abdominal pain (possibly radiating to the back), stop taking Rybelsus and seek urgent medical attention as this could indicate pancreatitis Regular monitoring of HbA1c, renal function, and body weight is recommended Increased risk of hypoglycaemia when used with insulin or sulfonylureas
